Latest Competition News

Osteopore Limited has announced a $20 million convertible notes offering aimed at bolstering its capital for ongoing operations and future projects. The highly speculative offer targets sophisticated investors and underscores the company’s strategic funding approach amid competitive medical device markets.

Teaminvest Private Group Limited updates on a $20 million legal victory now under appeal, alongside strategic franchise growth and a new secured loan to accelerate expansion.

Green Technology Metals (ASX: GT1) confirms production of high-quality spodumene concentrate from its Seymour Project in Ontario, reinforcing a streamlined DMS processing approach and advancing project feasibility.

AGL Energy reported solid FY25 half-year results with underlying EBITDA of $1.068 billion and narrowed guidance, underscoring its commitment to a sustainable energy transition through significant investments in grid-scale batteries and renewables.

St George Mining has forged a strategic partnership with global EPC leader Xinhai, securing an A$8 million investment and a pathway to fast-track the Araxá niobium-REE project in Brazil.

AGL Energy reported a solid first half of FY25 with underlying EBITDA slightly down but maintained strong operational momentum, while narrowing its full-year earnings guidance and announcing key leadership changes.

Dexus Industria REIT has reported a robust half-year performance for FY25, driven by high occupancy, significant leasing activity, and successful completion of a key development at ASCEND at Jandakot.

Bravura Solutions has delivered a solid 1H25 performance marked by modest revenue growth and significant profit improvements, prompting an upgraded FY25 outlook and a special dividend announcement.

Predictive Discovery Limited has successfully completed a A$69.2 million strategic placement with key investors Lundin family and Zijin Mining Group, strengthening its financial position for future growth.

Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.

IMDEX Limited reported a significant 84% increase in net profit for the half-year ended December 31, 2024, even as revenue declined by 10%. The company declared a steady interim dividend, underscoring confidence amid mixed financial signals.

EMVision Medical Devices has secured US ethics approval for its pivotal multi-centre trial of the EMVision emu™ brain scanner, paving the way for a March 2025 trial start aimed at FDA clearance.